NVIDIA BioNeMo Service

Accelerate early drug discovery with generative AI.

What Is BioNeMo?

NVIDIA BioNeMo Service is a cloud service for generative AI in drug discovery. With NVIDIA cloud APIs, researchers can quickly customize and deploy domain-specific, state-of-the-art generative and predictive biomolecular AI models at scale. BioNeMo enables researchers and developers to use generative AI models to rapidly generate the structure and function of proteins and biomolecules, accelerating the creation of new drug candidates.

Accelerate AI-Powered Drug Discovery With BioNeMo

Learn how BioNeMo’s user-friendly interface and optimized training and inferencing routines are paired with on-demand supercomputing infrastructure to support the most expensive, time-consuming stages of early drug discovery pipelines.

Explore Features and Benefits

State-of-the-Art Biomolecular Models for AI Drug Discovery

Customize and deploy AI models for 3D protein structure prediction, de novo protein and small molecule generation, property predictions, and molecular docking.

Turnkey Solution Through a Web Interface or Cloud APIs

Access pretrained models through cloud APIs or an easy-to-use web interface for interactive inference, visualization, and experimentation.

Training and Optimization on an AI Supercomputer in the Cloud

Optimize and train models with NVIDIA DGX™ Cloud, the multi-node AI training-as-a-service solution.

Sign up for early access to BioNeMo Service.

Find More Resources

Must-Reads

Read how BioNeMo will enable end-to-end modular drug discovery—accelerating research and understanding of proteins, DNA, and chemicals.

Bridge the Gap

Check out the GTC session “AI-Powered Drug Discovery for Generative Chemistry and Proteins, Including NVIDIA BioNeMo.”

Join the Community

Bookmark the BioNeMo Developer Forum to see what others are doing and ask your questions.